EEG-IP: an international infant EEG data integration platform for the study of risk and resilience in autism and related conditions.
Autism risk
Biomarkers
EEG
High performance computing
ICA
Pre-processing
Journal
Molecular medicine (Cambridge, Mass.)
ISSN: 1528-3658
Titre abrégé: Mol Med
Pays: England
ID NLM: 9501023
Informations de publication
Date de publication:
07 05 2020
07 05 2020
Historique:
received:
03
10
2019
accepted:
14
02
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
10
8
2021
Statut:
epublish
Résumé
Establishing reliable predictive and diganostic biomarkers of autism would enhance early identification and facilitate targeted intervention during periods of greatest plasticity in early brain development. High impact research on biomarkers is currently limited by relatively small sample sizes and the complexity of the autism phenotype. EEG-IP is an International Infant EEG Data Integration Platform developed to advance biomarker discovery by enhancing the large scale integration of multi-site data. Currently, this is the largest multi-site standardized dataset of infant EEG data. First, multi-site data from longitudinal cohort studies of infants at risk for autism was pooled in a common repository with 1382 EEG longitudinal recordings, linked behavioral data, from 432 infants between 3- to 36-months of age. Second, to address challenges of limited comparability across independent recordings, EEG-IP applied the Brain Imaging Data Structure (BIDS)-EEG standard, resulting in a harmonized, extendable, and integrated data state. Finally, the pooled and harmonized raw data was preprocessed using a common signal processing pipeline that maximizes signal isolation and minimizes data reduction. With EEG-IP, we produced a fully standardized data set, of the pooled, harmonized, and pre-processed EEG data from multiple sites. Implementing these integrated solutions for the first time with infant data has demonstrated success and challenges in generating a standardized multi-site data state. The challenges relate to annotation of signal sources, time, and ICA analysis during pre-processing. A number of future opportunities also emerge, including validation of analytic pipelines that can replicate existing findings and/or test novel hypotheses.
Sections du résumé
BACKGROUND
Establishing reliable predictive and diganostic biomarkers of autism would enhance early identification and facilitate targeted intervention during periods of greatest plasticity in early brain development. High impact research on biomarkers is currently limited by relatively small sample sizes and the complexity of the autism phenotype.
METHODS
EEG-IP is an International Infant EEG Data Integration Platform developed to advance biomarker discovery by enhancing the large scale integration of multi-site data. Currently, this is the largest multi-site standardized dataset of infant EEG data.
RESULTS
First, multi-site data from longitudinal cohort studies of infants at risk for autism was pooled in a common repository with 1382 EEG longitudinal recordings, linked behavioral data, from 432 infants between 3- to 36-months of age. Second, to address challenges of limited comparability across independent recordings, EEG-IP applied the Brain Imaging Data Structure (BIDS)-EEG standard, resulting in a harmonized, extendable, and integrated data state. Finally, the pooled and harmonized raw data was preprocessed using a common signal processing pipeline that maximizes signal isolation and minimizes data reduction. With EEG-IP, we produced a fully standardized data set, of the pooled, harmonized, and pre-processed EEG data from multiple sites.
CONCLUSIONS
Implementing these integrated solutions for the first time with infant data has demonstrated success and challenges in generating a standardized multi-site data state. The challenges relate to annotation of signal sources, time, and ICA analysis during pre-processing. A number of future opportunities also emerge, including validation of analytic pipelines that can replicate existing findings and/or test novel hypotheses.
Identifiants
pubmed: 32380941
doi: 10.1186/s10020-020-00149-3
pii: 10.1186/s10020-020-00149-3
pmc: PMC7203847
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Subventions
Organisme : NICHD NIH HHS
ID : P50 HD055782
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103524
Pays : United States
Organisme : NIMH NIH HHS
ID : U19 MH108206
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Références
Neuron. 2017 Aug 30;95(5):1002-1006
pubmed: 28858611
Pediatrics. 2011 Sep;128(3):e488-95
pubmed: 21844053
Biol Psychiatry. 2013 Aug 1;74(3):189-94
pubmed: 23374640
Front Neurosci. 2018 Feb 27;12:97
pubmed: 29535597
Biol Psychiatry. 2016 Jul 15;80(2):94-99
pubmed: 27113503
PLoS One. 2012;7(6):e39127
pubmed: 22745707
Sci Rep. 2018 Jan 15;8(1):715
pubmed: 29335488
Sci Data. 2016 Jun 21;3:160044
pubmed: 27326542
Physiol Meas. 2012 Aug;33(8):N39-49
pubmed: 22814032
Psychophysiology. 2011 Dec;48(12):1711-25
pubmed: 21895683
J Neurodev Disord. 2017 Sep 13;9(1):34
pubmed: 28903722
Curr Biol. 2012 Feb 21;22(4):338-42
pubmed: 22285033
J Neurodev Disord. 2014;6(1):40
pubmed: 25400705
J Autism Dev Disord. 2015 Feb;45(2):425-43
pubmed: 23975145
Front Neurosci. 2018 Aug 07;12:513
pubmed: 30131667
J Autism Dev Disord. 2015 Feb;45(2):283-91
pubmed: 25074759
Front Neuroinform. 2015 Jun 18;9:16
pubmed: 26150785
Front Neuroinform. 2017 Jan 06;10:53
pubmed: 28111547
Behav Brain Res. 2018 Jul 16;347:425-435
pubmed: 29574102
J Neurodev Disord. 2016 Mar 15;8:7
pubmed: 26981158
Mol Psychiatry. 2014 Jun;19(6):659-67
pubmed: 23774715
Biol Psychiatry. 2018 Apr 1;83(7):579-588
pubmed: 29146048
BMC Med. 2011 Feb 22;9:18
pubmed: 21342500
Sci Rep. 2018 May 1;8(1):6828
pubmed: 29717196
Neuroimage. 2016 Jan 1;124(Pt B):1188-1195
pubmed: 26364860
Biol Psychiatry. 2009 Jan 1;65(1):31-8
pubmed: 19064038
Front Integr Neurosci. 2019 Aug 21;13:45
pubmed: 31496945
PLoS One. 2014 Aug 20;9(8):e105176
pubmed: 25140874
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Mar;5(3):342-353
pubmed: 31679960
Proc Biol Sci. 2013 Mar 13;280(1758):20123026
pubmed: 23486434
PLoS One. 2017 May 3;12(5):e0175870
pubmed: 28467487
MNI Open Res. 2018;2:5
pubmed: 33937623
Curr Opin Neurol. 2015 Apr;28(2):110-6
pubmed: 25710286
Sci Data. 2019 Jun 25;6(1):103
pubmed: 31239435